Submitting comments on IQWiG's assessments

You can comment on intermediate stages of our benefit assessments and point out further aspects or missing data.

After the publication of preliminary report plans and preliminary reports, a commenting procedure is regularly conducted. You can also find information on current commenting procedures on our homepage and via the IQWiG info service.

Please only use the forms and guidelines available on the webpage of the respective IQWiG report for your comments.

Current commenting procedures (Hearings)

DeadlineTitle of commissionType of comment
2018-01-24 Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies on the preliminary report
2018-01-30 Motor-driven continuous passive motion (CPM) devices after interventions on the knee and shoulder joint on the preliminary report

Note: Commenting procedures are also conducted for early benefit assessments of drugs pursuant to AMNOG (dossier assessments), for assessments of the potential of non-drug interventions, and for the assessment according to §137h SGB V. However, these are not conducted by IQWiG, but by the Federal Joint Committee (G-BA). The G-BA’s website provides information on the commenting procedures for early benefit assessments of drugs, for assessments of the potential and testing of non-drug interventions, and for assessments according to §137h (german Version).

Save result list

To save your search result, please copy the link below and paste it into a new tab/window.